Background
Diabetes mellitus (DM) is linked to an increased risk of lung cancer; however, the exact molecular basis is unclear.
Methods
We used a microarray method and found a group of microRNAs differently expressed in lung cancer cells at high or low glucose treatment.
Results
Among these, miR‐194 changed significantly, which indicated further analysis. miR‐194 was significantly downregulated in non‐small cell lung cancer (NSCLC) cells cultured in high glucose (HG) medium and clinical NSCLC tissues with DM. The introduction of miR‐194 significantly suppressed the proliferation, migration, and invasion of lung cancer cells induced by HG, suggesting that miR‐194 may be a suppressor during HG‐induced NSCLC progression. Further analysis indicated that
NFAT5
was a direct target gene of miR‐194, evidenced by the direct binding of miR‐194 with the 3’untranslated region of
NFAT5
. MiR‐194 could decrease the expression of
NFAT5
at both messenger RNA and protein levels, while overexpression of
NFAT5
reversed the decreased proliferation, migration, and invasion ability mediated by miR‐194 in lung cancer cells.
Conclusion
Our findings provide new insight into the mechanism of NSCLC progression. Therapeutically, miR‐194 may serve as a potential target for the treatment of lung cancer patients with DM.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.